Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Imaging the progression of Alzheimer pathology through the brain.

Smith AD.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4135-7. No abstract available.

2.

Atrophy rate in medial temporal lobe during progression of Alzheimer disease.

Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ.

Neurology. 2004 Dec 28;63(12):2354-9.

PMID:
15623699
3.

Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD.

van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Spilt A, Bollen EL, Westendorp RG, van Buchem MA.

Neurology. 2004 May 25;62(10):1862-4.

PMID:
15159496
4.

Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?

Korf ES, Scheltens P, Barkhof F, de Leeuw FE.

Dement Geriatr Cogn Disord. 2005;20(6):331-7. Epub 2005 Sep 22.

PMID:
16179827
5.

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J.

J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7.

6.

The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.

Davis PC, Gearing M, Gray L, Mirra SS, Morris JC, Edland SD, Lin T, Heyman A.

Neurology. 1995 Jan;45(1):178-9.

PMID:
7824112
7.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
8.

[Contribution of morphological imaging in the diagnosis of dementia. I--Alzheimer disease].

Scheltens P, Leys D, Barkhof F, Vermersch P, Steinling M, Weinstein HC, Pruvo JP, Petit H.

Rev Med Interne. 1994 May;15(6):415-22. Review. French.

PMID:
8059176
9.

Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity.

Murphy DG, DeCarli CD, Daly E, Gillette JA, McIntosh AR, Haxby JV, Teichberg D, Schapiro MB, Rapoport SI, Horwitz B.

Biol Psychiatry. 1993 Nov 1;34(9):612-21.

PMID:
8292690
10.

Impact commentaries. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Scheltens P, van de Pol L.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1038-40. doi: 10.1136/jnnp-2012-302562. Epub 2012 May 7. No abstract available.

11.

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.

Neurology. 2005 Mar 8;64(5):861-5.

PMID:
15753423
12.

Medial temporal atrophy as a magnetic resonance imaging marker for Alzheimer's disease.

Barclay LL, Linden C, Murtagh R.

J Neuroimaging. 1992 Jul;2(3):131-5.

PMID:
10171577
13.

Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.

Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN.

Ann Neurol. 2001 Apr;49(4):433-42.

PMID:
11310620
14.

White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.

de Leeuw FE, Korf E, Barkhof F, Scheltens P.

Stroke. 2006 Sep;37(9):2248-52. Epub 2006 Aug 10.

15.

Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.

Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P, van der Flier WM.

Stroke. 2009 Apr;40(4):1269-74. doi: 10.1161/STROKEAHA.108.531343. Epub 2009 Feb 19.

16.

[Neuroimaging for patients with Alzheimer disease in routine practice].

Matsuda H.

Brain Nerve. 2010 Jul;62(7):743-55. Review. Japanese.

PMID:
20675879
17.

Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.

Tanaka S, Kawamata J, Shimohama S, Akaki H, Akiguchi I, Kimura J, Ueda K.

Dement Geriatr Cogn Disord. 1998 Mar-Apr;9(2):90-8.

PMID:
9524800
18.

Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age.

van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Bollen EL, Westendorp RG, van Buchem MA.

Dement Geriatr Cogn Disord. 2005;20(2-3):82-8. Epub 2005 May 23.

19.

Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry.

Wahlund LO, Julin P, Lindqvist J, Scheltens P.

Psychiatry Res. 1999 Jun 30;90(3):193-9.

PMID:
10466738
20.

Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia.

Galton CJ, Gomez-Anson B, Antoun N, Scheltens P, Patterson K, Graves M, Sahakian BJ, Hodges JR.

J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):165-73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk